NADER EL-MALLAWANY

TitleAssociate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
Address1102 BATES
Houston, TX 77030
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R21CA217137     (EL-MALLAWANY, NADER KIM)Aug 1, 2017 - Jul 31, 2020
    NIH
    (PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Bielamowicz K, Dimitrion P, Abla O, Bomken S, Campbell P, Collin M, Degar B, Diamond EL, Eckstein OS, El-Mallawany N, Fluchel M, Goyal G, Henry MM, Hermiston M, Hogarty M, Jeng M, Jubran R, Lubega J, Kumar A, Ladisch S, McClain KL, Merad M, Mi QS, Parsons DW, Peckham-Gregory E, Picarsic J, Prudowsky ZD, Rollins BJ, Shaw PH, Wistinghausen B, Rodriguez-Galindo C, Allen CE, North American Consortium for Histiocytosis. Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Cancer. 2024 Jul 15; 130(14):2416-2439. PMID: 38687639; PMCID: PMC11214602.
      Citations:    Fields:    Translation:Humans
    2. Parekh D, Lin H, Batajoo A, Peckham-Gregory E, Karri V, Stanton W, Scull B, Fleishmann R, El-Mallawany N, Eckstein OS, Prudowsky ZD, Gulati N, Agrusa JE, Ahmed AZ, Chu R, Dietz MS, Goldman SC, Hogarty MD, Imran H, Intzes S, Kim JM, Kopp LM, Levy CF, Neff P, Sisk BA, Schiff DE, Trobaugh-Lotrario AD, Walkovich K, McClain KL, Allen CE, Pillai PM. Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis. Br J Haematol. 2024 May; 204(5):1888-1893. PMID: 38501389.
      Citations:    Fields:    Translation:Humans
    3. Karri V, Lin H, Velazquez J, Batajoo A, Parekh D, Stanton W, Abhyankar H, El-Mallawany NK, Agrusa J, Eckstein O, Gulati N, Schwartz J, Woods-Stafford W, Boyd J, Saha A, Allen CE, McClain KL, Woods-Swafford W. Clinical, radiological and molecular responses to combination chemotherapy with MAPK pathway inhibition in relapsed and refractory Langerhans cell histiocytosis. Br J Haematol. 2024 May; 204(5):1882-1887. PMID: 38501390.
      Citations:    Fields:    Translation:HumansCells
    4. El Dana F, Garces Narvaez SA, El-Mallawany NK, Agrusa JE, Dreyer ZE, Marcogliese AN, Elghetany MT, Punia JN, Ok CY, Patel KP, Lopez-Terrada DH, Fisher KE, Curry CV. Childhood and Adolescent Relapsed/Refractory Aggressive B-Cell Lymphomas With t(8;14) and BCL2 Expression, Burkitt Lymphoma Versus Diffuse Large B-Cell Lymphoma: A Diagnostic Challenge. Pediatr Dev Pathol. 2024 Mar 11; 10935266241230600. PMID: 38468555.
      Citations:    Fields:    
    5. Deng Q, Lakra P, Gou P, Yang H, Meydan C, Teater M, Chin C, Zhang W, Dinh T, Hussein U, Li X, Rojas E, Liu W, Reville PK, Kizhakeyil A, Barisic D, Parsons S, Wilson A, Henderson J, Scull B, Gurumurthy C, Vega F, Chadburn A, Cuglievan B, El-Mallawany NK, Allen C, Mason C, Melnick A, Green MR. SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions. Cancer Cell. 2024 Apr 08; 42(4):605-622.e11. PMID: 38458188; PMCID: PMC11003852.
      Citations:    Fields:    Translation:HumansAnimalsCells
    6. Caro-Vegas C, Peng A, Juarez A, Silverstein A, Kamiyango W, Villiera J, McAtee CL, Mzikamanda R, Tomoka T, Peckham-Gregory EC, Moorad R, Kovarik CL, Campbell LR, Mehta PS, Kazembe PN, Allen CE, Scheurer ME, Ozuah NW, Dittmer DP, El-Mallawany NK. Pediatric HIV+ Kaposi sarcoma exhibits clinical, virological, and molecular features different from the adult disease. JCI Insight. 2023 Nov 22; 8(22). PMID: 37991023; PMCID: PMC10721314.
      Citations:    Fields:    Translation:HumansCells
    7. El-Mallawany NK, Giulino-Roth L, Burke JM, Hermiston M, Allen CE. Mature B-cell lymphomas in adolescents and young adults. EJHaem. 2023 Nov; 4(4):912-920. PMID: 38024628; PMCID: PMC10660408.
      Citations:    
    8. El-Mallawany NK, Kamdar KY. Evolving beyond morphology in pediatric PTLD. Blood. 2023 08 03; 142(5):400-402. PMID: 37535368.
      Citations:    Fields:    Translation:Humans
    9. El-Mallawany NK, Alexander S, Fluchel M, Hayashi RJ, Lowe EJ, Giulino-Roth L, Wistinghausen B, Hermiston M, Allen CE, COG NHL Committee. Children's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30565. PMID: 37449925; PMCID: PMC10577684.
      Citations: 2     Fields:    Translation:Humans
    10. Stokke J, Tann A, El-Mallawany NK, Oschlies I. Diagnosis and management of cutaneous lymphomas and lymphoid proliferations in children, adolescents and young adults (CAYA). Best Pract Res Clin Haematol. 2023 03; 36(1):101448. PMID: 36907638.
      Citations:    Fields:    Translation:Humans
    11. Campbell LR, Silverstein A, Peckham-Gregory E, Kamiyango W, Villiera J, McAtee CL, Bacha JM, Kovarik CL, Mehta PS, Chanroo T, Kapesa A, Malingoti B, Mzikamanda R, Ozuah NW, Allen CE, Scheurer ME, El-Mallawany NK. Divergent clinical presentations and outcomes among children and adolescents with Kaposi sarcoma in Malawi and Tanzania. HIV Med. 2023 06; 24(6):664-675. PMID: 36627111; PMCID: PMC10257738.
      Citations:    Fields:    Translation:Humans
    12. Gardenswartz A, Mehta B, El-Mallawany NK, van de Ven C, Hochberg J, Flower A, Morris E, Harrison L, Chu Y, Basso J, Gerard P, Islam H, Ayello J, Baxter-Lowe LA, Cairo MS. Safety and efficacy of combinatorial therapy utilizing myeloablative conditioning and autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed/refractory mature B-cell non-Hodgkin lymphoma. Leuk Lymphoma. 2023 01; 64(1):234-237. PMID: 36260003.
      Citations: 1     Fields:    Translation:Humans
    13. Bernhardt MB, Brown AL, Grim AT, Scheurer ME, El-Mallawany NK, Ozuah NW. Safety analysis of high-dose methotrexate in pediatric non-Hodgkin lymphomas. Pediatr Blood Cancer. 2022 11; 69(11):e29940. PMID: 36069680; PMCID: PMC10707448.
      Citations:    
    14. Silverstein A, Kamiyango W, Villiera J, Peckham-Gregory EC, McAtee CL, Scheurer ME, Cox CM, Kovarik CL, Campbell LR, Allen CE, Mehta PS, Kazembe PN, Ozuah NW, El-Mallawany NK. Long-term outcomes for children and adolescents with Kaposi sarcoma. HIV Med. 2022 02; 23(2):197-203. PMID: 34634187; PMCID: PMC9121366.
      Citations:    Fields:    Translation:Humans
    15. Forbes LR, Eckstein OS, Gulati N, Peckham-Gregory EC, Ozuah NW, Lubega J, El-Mallawany NK, Agrusa JE, Vogel TP, Chaimowitz NS, Rider NL, Mace EM, Orange JS, Caldwell JW, Aldave-Becerra JC, Jolles S, Saettini F, Chong HJ, Stray-Pedersen A, Heslop HE, Kamdar KY, Rouce RH, Muzny DM, Jhangiani SN, Gibbs RA, Coban-Akdemir ZH, Lupski JR, McClain KL, Allen CE, Chinn IK, Poli MC. Genetic errors of immunity distinguish pediatric nonmalignant lymphoproliferative disorders. J Allergy Clin Immunol. 2022 02; 149(2):758-766. PMID: 34329649; PMCID: PMC8795244.
      Citations: 1     Fields:    Translation:HumansCells
    16. Campbell LR, El-Mallawany NK, Slone JS, Malingoti BM, Mehta PS, Scheurer ME, Bacha JM, Peckham-Gregory EC. Clinical characteristics and successful treatment outcomes of children and adolescents with Kaposi sarcoma in Southwestern Tanzania. Pediatr Hematol Oncol. 2022 Feb; 39(1):28-47. PMID: 34243680.
      Citations:    Fields:    Translation:Humans
    17. El-Mallawany NK, Curry CV, Allen CE. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes. Br J Haematol. 2022 01; 196(1):31-44. PMID: 34169507.
      Citations: 4     Fields:    Translation:HumansCells
    18. Adinani H, Campbell L, El-Mallawany NK, Slone J, Mehta P, Bacha J. Use of Paclitaxel to Successfully Treat Children, Adolescents, and Young Adults with Kaposi Sarcoma in Southwestern Tanzania. Children (Basel). 2021 Apr 02; 8(4). PMID: 33918352; PMCID: PMC8067189.
      Citations: 1     
    19. Haq H, Elyanu P, Bulsara S, Bacha JM, Campbell LR, El-Mallawany NK, Keating EM, Kisitu GP, Mehta PS, Rees CA, Slone JS, Kekitiinwa AR, Matshaba M, Mizwa MB, Mwita L, Schutze GE, Wanless SR, Scheurer ME, Lubega J. Association between Antiretroviral Therapy and Cancers among Children Living with HIV in Sub-Saharan Africa. Cancers (Basel). 2021 Mar 18; 13(6). PMID: 33803641; PMCID: PMC8003101.
      Citations: 2     
    20. Agrusa JE, Scull BP, Abhyankar HA, Lin H, Ozuah NW, Chakraborty R, Eckstein OS, Gulati N, Fattah EA, El-Mallawany NK, Rouce RH, Dreyer ZE, Brackett J, Margolin JF, Lubega J, Horton TM, Bollard CM, Gramatges MM, Kamdar KY, McClain KL, Man TK, Allen CE. Defining the Inflammatory Plasma Proteome in Pediatric Hodgkin Lymphoma. Cancers (Basel). 2020 Dec 02; 12(12). PMID: 33276546; PMCID: PMC7761312.
      Citations: 1     
    21. Ozuah NW, Lubega J, Allen CE, El-Mallawany NK. Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa. Blood Adv. 2020 08 25; 4(16):4007-4019. PMID: 32841337; PMCID: PMC7448606.
      Citations: 3     Fields:    Translation:Humans
    22. Bacha JM, El-Mallawany NK, Slone JS, Wilkinson JP, Mehta PS, Campbell LR. Recommendations for treating life-threatening Kaposi sarcoma during pregnancy in HIV-positive women in low income countries. Int J STD AIDS. 2020 07; 31(8):724-734. PMID: 32493141.
      Citations: 1     Fields:    Translation:Humans
    23. McCormick DW, Bacha JM, El-Mallawany NK, Kovarik CL, Slone JS, Campbell LR. Disseminated cysticercosis and Kaposi sarcoma in a child with HIV/AIDS: A case report. BMC Infect Dis. 2020 Apr 25; 20(1):309. PMID: 32334521; PMCID: PMC7183726.
      Citations:    Fields:    Translation:HumansAnimals
    24. El-Mallawany NK, McClain KL. Checkmate for EBV-HLH. Blood. 2020 03 12; 135(11):782-784. PMID: 32163559.
      Citations: 1     Fields:    Translation:HumansCells
    25. Kamiyango W, Villiera J, Silverstein A, Peckham-Gregory E, Campbell LR, El-Mallawany NK. Navigating the heterogeneous landscape of pediatric Kaposi sarcoma. Cancer Metastasis Rev. 2019 12; 38(4):749-758. PMID: 31845111; PMCID: PMC7050576.
      Citations: 4     Fields:    Translation:Humans
    26. El-Mallawany NK, Kamiyango W, Villiera J, Peckham-Gregory EC, Scheurer ME, McAtee CL, Allen CE, Kovarik CL, Frank D, Eason AB, Caro-Vegas C, Chiao EY, Schutze GE, Ozuah NW, Mehta PS, Kazembe PN, Dittmer DP. Kaposi Sarcoma Herpesvirus Inflammatory Cytokine Syndrome-like Clinical Presentation in Human Immunodeficiency Virus-infected Children in Malawi. Clin Infect Dis. 2019 11 13; 69(11):2022-2025. PMID: 31102440; PMCID: PMC6853646.
      Citations: 4     Fields:    Translation:HumansCells
    27. Coffey AM, Lewis A, Marcogliese AN, Elghetany MT, Punia JN, Chang CC, Allen CE, McClain KL, Gaikwad AS, El-Mallawany NK, Curry CV. A clinicopathologic study of the spectrum of systemic forms of EBV-associated T-cell lymphoproliferative disorders of childhood: A single tertiary care pediatric institution experience in North America. Pediatr Blood Cancer. 2019 08; 66(8):e27798. PMID: 31099136.
      Citations: 3     Fields:    Translation:HumansCellsCTClinical Trials
    28. Painschab MS, Westmoreland KD, Kasonkanji E, Zuze T, Kaimila B, Waswa P, El-Mallawany NK, Tomoka T, Mulenga M, Montgomery ND, Fedoriw Y, Gopal S. Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi. Blood Adv. 2019 02 26; 3(4):612-620. PMID: 30796065; PMCID: PMC6391663.
      Citations: 8     Fields:    Translation:Humans
    29. El-Mallawany NK, Villiera J, Kamiyango W, Peckham-Gregory EC, Scheurer ME, Allen CE, McAtee CL, Legarreta A, Dittmer DP, Kovarik CL, Chiao EY, Martin SC, Ozuah NW, Mehta PS, Kazembe PN. Endemic Kaposi sarcoma in HIV-negative children and adolescents: an evaluation of overlapping and distinct clinical features in comparison with HIV-related disease. Infect Agent Cancer. 2018; 13:33. PMID: 30455728; PMCID: PMC6230225.
      Citations: 7     
    30. El-Mallawany NK, Mehta PS, Kamiyango W, Villiera J, Peckham-Gregory EC, Kampani C, Krysiak R, Sanders MK, Caro-Vegas C, Eason AB, Ahmed S, Schutze GE, Martin SC, Kazembe PN, Scheurer ME, Dittmer DP. KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions. Int J Cancer. 2019 01 01; 144(1):110-116. PMID: 30204240; PMCID: PMC6261676.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    31. Chang E, Mapakshi SR, Mbang P, El-Mallawany NK, Kramer JR, White DL, Chiao EY. Impact of Protease Inhibitors on HIV-Associated Kaposi Sarcoma Incidence: A Systematic Review. J Acquir Immune Defic Syndr. 2018 10 01; 79(2):141-148. PMID: 29985803; PMCID: PMC9415696.
      Citations: 4     Fields:    Translation:Humans
    32. El-Mallawany NK, McAtee CL, Campbell LR, Kazembe PN. Pediatric Kaposi sarcoma in context of the HIV epidemic in sub-Saharan Africa: current perspectives. Pediatric Health Med Ther. 2018; 9:35-46. PMID: 29722363; PMCID: PMC5919159.
      Citations: 11     
    33. El-Mallawany NK, Kamiyango W, Villiera J, Slone JS, Kovarik CL, Campbell LR, Agrawal AK, Dittmer DP, Eason AB, Ahmed S, Schutze GE, Scheurer ME, Kazembe PN, Mehta PS. Proposal of a Risk-Stratification Platform to Address Distinct Clinical Features of Pediatric Kaposi Sarcoma in Lilongwe, Malawi. J Glob Oncol. 2018 09; 4:1-7. PMID: 29272148; PMCID: PMC6180767.
      Citations: 9     Fields:    Translation:Humans
    34. El-Mallawany NK, Wasswa P, Mtete I, Mutai M, Stanley CC, Mtunda M, Chasela M, Mpasa A, Wachepa S, Kamiyango W, Villiera J, Kazembe PN, Mehta PS. Identifying opportunities to bridge disparity gaps in curing childhood cancer in Malawi: Malignancies with excellent curative potential account for the majority of diagnoses. Pediatr Hematol Oncol. 2017 Aug; 34(5):261-274. PMID: 29190181.
      Citations: 4     Fields:    Translation:Humans
    35. Stanley CC, van der Gronde T, Westmoreland KD, Salima A, Amuquandoh A, Itimu S, Manda A, Mtete I, Butia M, Mpasa A, Wachepa S, Fox P, Wasswa P, Kazembe P, El-Mallawany NK, Gopal S. Risk factors and reasons for treatment abandonment among children with lymphoma in Malawi. Support Care Cancer. 2018 Mar; 26(3):967-973. PMID: 28986643; PMCID: PMC5786474.
      Citations: 7     Fields:    Translation:Humans
    36. Miller H, Slone JS, Raabe E, El-Mallawany NK, Mehta P, Phelps BR. Lessons From Pediatric HIV: A Case for Curative Intent in Pediatric Cancer in LMICs. Pediatrics. 2017 10; 140(4). PMID: 28912367; PMCID: PMC5613823.
      Citations: 3     Fields:    Translation:Humans
    37. Westmoreland KD, El-Mallawany NK, Kazembe P, Stanley CC, Gopal S. Dissecting heterogeneous outcomes for paediatric Burkitt lymphoma in Malawi after anthracycline-based treatment. Br J Haematol. 2018 06; 181(6):853-854. PMID: 28714257; PMCID: PMC5771980.
      Citations: 3     Fields:    Translation:Humans
    38. El-Mallawany NK, Mutai M, Mtete I, Gopal S, Stanley CC, Wasswa P, Mtunda M, Chasela M, Kamiyango W, Villiera J, Fedoriw Y, Montgomery ND, Liomba GN, Kampani C, Krysiak R, Westmoreland KD, Kim MH, Slone JS, Scheurer ME, Allen CE, Mehta PS, Kazembe PN. Beyond Endemic Burkitt Lymphoma: Navigating Challenges of Differentiating Childhood Lymphoma Diagnoses Amid Limitations in Pathology Resources in Lilongwe, Malawi. Glob Pediatr Health. 2017; 4:2333794X17715831. PMID: 28680947; PMCID: PMC5484428.
      Citations: 2     
    39. Lee S, Day NS, Miles RR, Perkins SL, Lim MS, Ayello J, van de Ven C, Harrison L, El-Mallawany NK, Goldman S, Cairo MS. Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report. Br J Haematol. 2017 05; 177(4):601-611. PMID: 28474336; PMCID: PMC5435544.
      Citations: 7     Fields:    Translation:HumansCells
    40. Westmoreland KD, Montgomery ND, Stanley CC, El-Mallawany NK, Wasswa P, van der Gronde T, Mtete I, Butia M, Itimu S, Chasela M, Mtunda M, Kampani C, Liomba NG, Tomoka T, Dhungel BM, Sanders MK, Krysiak R, Kazembe P, Dittmer DP, Fedoriw Y, Gopal S. Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi. Int J Cancer. 2017 06 01; 140(11):2509-2516. PMID: 28268254; PMCID: PMC5386821.
      Citations: 15     Fields:    Translation:HumansCells
    41. El-Mallawany NK, Villiera J, Kamiyango W, Mhango J, Slone JS, Mehta PS, Kazembe PN, Scheurer ME. Increasing Numbers of New Kaposi Sarcoma Diagnoses in HIV-Infected Children and Adolescents Despite the Wide Availability of Antiretroviral Therapy in Malawi. Clin Infect Dis. 2017 03 15; 64(6):818-819. PMID: 28077522; PMCID: PMC6543771.
      Citations: 9     Fields:    Translation:HumansCells
    42. Stanley CC, Westmoreland KD, Itimu S, Salima A, van der Gronde T, Wasswa P, Mtete I, Butia M, El-Mallawany NK, Gopal S. Quantifying bias in survival estimates resulting from loss to follow-up among children with lymphoma in Malawi. Pediatr Blood Cancer. 2017 06; 64(6). PMID: 27896944; PMCID: PMC5520975.
      Citations: 10     Fields:    Translation:Humans
    43. Westmoreland KD, Stanley CC, Montgomery ND, Kaimila B, Kasonkanji E, El-Mallawany NK, Wasswa P, Mtete I, Butia M, Itimu S, Chasela M, Mtunda M, Chikasema M, Makwakwa V, Kampani C, Dhungel BM, Sanders MK, Krysiak R, Tomoka T, Liomba NG, Dittmer DP, Fedoriw Y, Gopal S. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study. Pediatr Blood Cancer. 2017 05; 64(5). PMID: 27781380; PMCID: PMC5529120.
      Citations: 14     Fields:    Translation:HumansCells
    44. El-Mallawany NK, Kamiyango W, Slone JS, Villiera J, Kovarik CL, Cox CM, Dittmer DP, Ahmed S, Schutze GE, Scheurer ME, Kazembe PN, Mehta PS. Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study. PLoS One. 2016; 11(4):e0153335. PMID: 27082863; PMCID: PMC4833299.
      Citations: 18     Fields:    Translation:HumansCells
    45. Hochberg J, El-Mallawany NK, Abla O. Adolescent and young adult non-Hodgkin lymphoma. Br J Haematol. 2016 05; 173(4):637-50. PMID: 27071675.
      Citations: 11     Fields:    Translation:Humans
    46. Stanley CC, Westmoreland KD, Heimlich BJ, El-Mallawany NK, Wasswa P, Mtete I, Butia M, Itimu S, Chasela M, Mtunda M, Chikasema M, Makwakwa V, Kaimila B, Kasonkanji E, Chimzimu F, Kampani C, Dhungel BM, Krysiak R, Montgomery ND, Fedoriw Y, Rosenberg NE, Liomba NG, Gopal S. Outcomes for paediatric Burkitt lymphoma treated with anthracycline-based therapy in Malawi. Br J Haematol. 2016 06; 173(5):705-12. PMID: 26914979; PMCID: PMC4884132.
      Citations: 21     Fields:    Translation:Humans
    47. El-Mallawany NK, Cairo MS. Advances in the diagnosis and treatment of childhood and adolescent B-cell non-Hodgkin lymphoma. Clin Adv Hematol Oncol. 2015 Feb; 13(2):113-23. PMID: 25774481.
      Citations: 12     Fields:    Translation:Humans
    48. El-Mallawany NK, Day N, Ayello J, Van de Ven C, Conlon K, Fermin D, Basrur V, Elenitoba-Johnson K, Lim M, Cairo MS. Differential proteomic analysis of endemic and sporadic Epstein-Barr virus-positive and negative Burkitt lymphoma. Eur J Cancer. 2015 Jan; 51(1):92-100. PMID: 25466511.
      Citations: 5     Fields:    Translation:HumansCells
    49. Hochberg J, El-Mallawany NK, Cairo MS. Humoral and cellular immunotherapy in ALL in children, adolescents, and young adults. Clin Lymphoma Myeloma Leuk. 2014 Sep; 14 Suppl:S6-13. PMID: 25486958.
      Citations: 3     Fields:    Translation:Humans
    50. Wanat KA, Reid E, Kamiyango W, El-Mallawany NK, Kovarik CL. Tumoral bacillary angiomatosis in a child with human immunodeficiency virus. JAMA Dermatol. 2014 Sep; 150(9):1015-6. PMID: 25076357.
      Citations: 4     Fields:    Translation:Humans
    51. Kambugu J, Kouya F, El-Mallawany NK, Hesseling PB, Kaspers GJ, Eden T, Renner L, Molyneux EM, Isra?ls T. Clinical trials to improve childhood cancer care and survival in sub-Saharan Africa. Nat Rev Clin Oncol. 2013 10; 10(10):599-604. PMID: 23897077.
      Citations: 10     Fields:    Translation:Humans
    52. Cox CM, El-Mallawany NK, Kabue M, Kovarik C, Schutze GE, Kazembe PN, Mehta PS. Clinical characteristics and outcomes of HIV-infected children diagnosed with Kaposi sarcoma in Malawi and Botswana. Pediatr Blood Cancer. 2013 Aug; 60(8):1274-80. PMID: 23487320.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    53. El-Mallawany NK, Frazer JK, Van Vlierberghe P, Ferrando AA, Perkins S, Lim M, Chu Y, Cairo MS. Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies. Blood Cancer J. 2012 Apr; 2(4):e65. PMID: 22829967; PMCID: PMC3346681.
      Citations: 5     Fields:    
    54. George D, El-Mallawany NK, Jin Z, Geyer M, Della-Latta P, Satwani P, Garvin JH, Bradley MB, Bhatia M, van de Ven C, Morris E, Schwartz J, Cairo MS. Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality. Br J Haematol. 2012 Jan; 156(1):99-108. PMID: 22008222.
      Citations: 7     Fields:    Translation:Humans
    55. Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, Gottschalk S, Bollard CM, Rao VK, Marques A, Burbelo PD, Turk SP, Fulton R, Wayne AS, Little RF, Cairo MS, El-Mallawany NK, Fowler D, Sportes C, Bishop MR, Wilson W, Straus SE. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011 Jun 02; 117(22):5835-49. PMID: 21454450; PMCID: PMC3112034.
      Citations: 100     Fields:    Translation:HumansCells
    56. El-Mallawany NK, Geller L, Bollard CM, Wistinghausen B, Mussai F, Wayne AS, Alobeid B, Cairo MS. Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy. Bone Marrow Transplant. 2011 May; 46(5):759-61. PMID: 20661233; PMCID: PMC3175617.
      Citations: 9     Fields:    Translation:HumansCells
    57. Sevilla DW, El-Mallawany NK, Emmons FN, Alexander S, Bhagat G, Alobeid B. Spectrum of childhood Epstein-Barr virus-associated T-cell proliferations and bone marrow findings. Pediatr Dev Pathol. 2011 Jan-Feb; 14(1):28-37. PMID: 20367453.
      Citations: 1     Fields:    Translation:HumansCells
    EL-MALLAWANY's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (202)
    Explore
    _
    Co-Authors (51)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _